Federal Register / Vol. 71, No. 229 / Wednesday, November 29, 2006 / Notices 69137 

Central Mid-Atlantic Division (RCP) 

Manages BPHC primary health care 

grant programs and activities within 

HHS Regions 3, 5 and 6. Specifically, for 

regions 3, 5 and 6: (1) Manages the postaward administration of the Bureau’s 

primary health care grant programs; (2) 

serves as the BPHC representative to 

organizations receiving Bureau grants; 

(3) promotes a continued focus on 

efficient and effective care for 

underserved and vulnerable 

populations; (4) communicates and 

interprets program statutory/regulatory 

requirements, policy, expectations and 

reporting requirements, providing 

technical guidance to grantees on the 

management and integration of 

community-based systems of care, the 

adaptation of successful strategies/ 

models, and the resolution of difficult 

issues; (5) monitors the performance of 

BPHC primary health care grantees, 

making programmatic recommendations 

and providing assistance to improve 

performance, where appropriate; (6) 

reviews findings and recommendations 

of periodic and episodic grantee 

assessments, developing actions needed 

to assure continuity of services to 

underserved and vulnerable populations 

and appropriate use of Federal 

resources; (7) identifies, provides and 

coordinates training and technical 

assistance activities for BPHC primary 

health care grant programs, including 

State-based training and technical 

assistance; (8) conducts State and 

regional surveillance on issues that 

affect BPHC grant programs; and (9) 

provides consultation to and 

coordinates activities within HRSA and 

HHS, and with other Federal agencies, 

State and local governments, and other 

public and private organizations 

involved in the implementation of 

program activities. 

Western Division (RCQ) 

Manages BPHC primary health care 

grant programs and activities within 

HHS Regions 7, 8, 9 and 10. 

Specifically, for regions 7, 8, 9 and 10: 

(1) Manages the post-award 

administration of the Bureau’s primary 

health care grant programs; (2) serves as 

the BPHC representative to 

organizations receiving Bureau grants; 

(3) promotes a continued focus on 

efficient and effective care for 

underserved and vulnerable 

populations; (4) communicates and 

interprets program statutory/regulatory 

requirements, policy, expectations and 

reporting requirements, providing 

technical guidance to grantees on the 

management and integration of 

community-based systems of care, the 

adaptation of successful strategies/ 

models, and the resolution of difficult 

issues; (5) monitors the performance of 

BPHC primary health care grantees, 

making programmatic recommendations 

and providing assistance to improve 

performance, where appropriate; (6) 

reviews findings and recommendations 

of periodic and episodic grantee 

assessments, developing actions needed 

to assure continuity of services to 

underserved and vulnerable populations 

and appropriate use of Federal 

resources; (7) identifies, provides and 

coordinates training and technical 

assistance activities for BPHC primary 

health care grant programs, including 

State-based training and technical 

assistance; (8) conducts State and 

regional surveillance on issues that 

affect BPHC grant programs; and (9) 

provides consultation to and 

coordinates activities within HRSA and 

HHS, and with other Federal agencies, 

State and local governments, and other 

public and private organizations 

involved in the implementation of 

program activities. 

Section RC–30, Delegations of Authority 

All delegations of authority and redelegations of authority made to HRSA 

officials that were in effect immediately 

prior to this reorganization, and that are 

consistent with this reorganization, 

shall continue in effect pending further 

re-delegation. 

This reorganization is effective upon 

the date of signature. 

November 7, 2006. 

Elizabeth M. Duke, 

Administrator. 

[FR Doc. E6–20171 Filed 11–28–06; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Amended Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the National Heart, Lung, 

and Blood Institute Special Emphasis 

Panel, December 12, 2006, 2 p.m. to 

December 12, 2006, 5 p.m., National 

Institutes of Health, 6701 Rockledge 

Drive, Bethesda, MD 20892 which was 

published in the Federal Register on 

November 3, 2006, FR–06–9030. 

The December 12, 2006 meeting date 

was changed to December 11, 2006. The 

meeting is closed to the public. 

Dated: November 21, 2006. 

David Clary, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–9457 Filed 11–28–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Health, Lung, and Blood 

Institute; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel; 

Childhood Asthma Follow-up Study. 

Date: November 28, 2006. 

Time: 10 a.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Telephone Conference Call). 

Contact Person: Valerie L. Prenger, PhD, 

Health Scientist Administrator, Division of 

Extramural Affairs, National Heart, Lung, and 

Blood Institute, 6701 Rockledge Drive, MSC 

7924, Room 7214, Bethesda, MD 20892–7924. 

(301) 435–0270. prengerv@nhlbi.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.233, National Center for 

Sleep Disorders Research; 93.837, Heart and 

Vascular Diseases Research; 93.838, Lung 

Diseases Research; 93.839, Blood Diseases 

and Resource Research, National Institute of 

Health, HHS) 

Dated: November 21, 2006. 

David Clary, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–9458 Filed 11–28–06; 8:45 am] 

BILLING CODE 4140–01–M 


jlentini on PROD1PC65 with NOTICES